A delivery system is part of the intervention, not just packaging around it. When a KPV paper studies an engineered carrier, the result cannot be reassigned to a plain capsule or a differently prepared solution simply because both contain a similarly named peptide.
What the delivery studies investigated
One primary study used hyaluronic-acid-functionalized nanoparticles in a hydrogel to deliver KPV in mouse colitis. Another mouse study investigated a different nanoparticle and polysaccharide-hydrogel system. Both explored ways to alter where the material was delivered and what inflammatory outcomes followed.
Those are preclinical formulation experiments. Their comparisons do not establish that a retail capsule duplicates the engineered system or reaches the same tissue exposure.
Why changing the carrier changes the question
The useful comparison is not merely how much peptide is listed on two labels. Researchers also need to understand release, distribution and what happens to the material before it reaches the intended site. A carrier may be designed precisely because free material behaves differently.
If an experiment reports that its delivery platform performs better than another preparation, that is evidence about the tested comparison. It is not a reason to convert the animal quantities into an oral human regimen. Species, formulation and clinical outcome remain unresolved.
What would connect a product with the paper
The product would need a clearly documented relationship to the tested material, and relevant studies would need to show that the intended exposure and outcome transfer. Merely citing the paper on a product page does not create that connection.
A plain preparation might eventually be studied separately; it should be judged on those results rather than borrowed carrier performance. The same principle applies to claims that all oral peptides must behave identically.
The main takeaway is formulation-specific: these papers demonstrate research into targeted delivery. They do not validate an ordinary capsule, a homemade mixture or a different catalog vial. This article describes that evidence boundary without providing a carrier recipe, concentration or administration instructions.